| Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension M Humbert, O Sitbon, A Yaïci, D Montani, DS O'callaghan, X Jaïs, ... European Respiratory Journal 36 (3), 549-555, 2010 | 808 | 2010 |
| Pulmonary arterial hypertension in patients treated by dasatinib D Montani, E Bergot, S Günther, L Savale, A Bergeron, A Bourdin, ... Circulation 125 (17), 2128-2137, 2012 | 784 | 2012 |
| A hemodynamic study of pulmonary hypertension in sickle cell disease F Parent, D Bachir, J Inamo, F Lionnet, F Driss, G Loko, A Habibi, ... New England Journal of Medicine 365 (1), 44-53, 2011 | 573 | 2011 |
| The role of inflammation in the pathogenesis of non-small cell lung cancer DS O'Callaghan, D O'Donnell, F O'Connell, KJ O'Byrne Journal of thoracic oncology 5 (12), 2024-2036, 2010 | 339 | 2010 |
| Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 (ALK1) Mutation B Girerd, D Montani, F Coulet, B Sztrymf, A Yaici, X Jaïs, D Tregouet, ... American journal of respiratory and critical care medicine 181 (8), 851-861, 2010 | 336 | 2010 |
| A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma G Garcia, A Magnan, R Chiron, C Contin-Bordes, P Berger, C Taillé, ... Chest 144 (2), 411-419, 2013 | 250 | 2013 |
| Treatment of pulmonary arterial hypertension with targeted therapies DS O'callaghan, L Savale, D Montani, X Jaïs, O Sitbon, G Simonneau, ... Nature Reviews Cardiology 8 (9), 526-538, 2011 | 187 | 2011 |
| Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study K Kemp, L Savale, DS O'Callaghan, X Jaïs, D Montani, M Humbert, ... The Journal of heart and lung transplantation 31 (2), 150-158, 2012 | 147 | 2012 |
| Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension L Savale, R Magnier, J Le Pavec, X Jaïs, D Montani, DS O'Callaghan, ... European Respiratory Journal 41 (1), 96-103, 2012 | 130 | 2012 |
| Pulmonary veno-occlusive disease: recent progress and current challenges D Montani, DS O’Callaghan, L Savale, X Jaïs, A Yaïci, S Maitre, ... Respiratory medicine 104, S23-S32, 2010 | 119 | 2010 |
| Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer DS O'Callaghan, E Rexhepaj, K Gately, L Coate, D Delaney, ... European Respiratory Journal 46 (6), 1762-1772, 2015 | 79 | 2015 |
| Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosis B Degano, O Sitbon, L Savale, G Garcia, DS O'Callaghan, X Jaïs, ... Chest 137 (6), 1297-1303, 2010 | 77 | 2010 |
| Pulmonary hypertension in patients with neurofibromatosis type I D Montani, F Coulet, B Girerd, M Eyries, E Bergot, H Mal, G Biondi, ... Medicine 90 (3), 201-211, 2011 | 75 | 2011 |
| Combination therapy and new types of agents for pulmonary arterial hypertension D O'Callaghan, SP Gaine Clinics in chest medicine 28 (1), 169-185, 2007 | 74 | 2007 |
| Pulmonary veno-occlusive disease: advances in clinical management and treatments A Huertas, B Girerd, P Dorfmuller, D O’Callaghan, M Humbert, D Montani Expert review of respiratory medicine 5 (2), 217-231, 2011 | 60 | 2011 |
| A critical analysis of survival in pulmonary arterial hypertension DS O'Callaghan, M Humbert European Respiratory Review 21 (125), 218-222, 2012 | 53 | 2012 |
| Pulmonary veno-occlusive disease: the bete noire of pulmonary hypertension in connective tissue diseases? DS O’Callaghan, P Dorfmuller, X Jaïs, L Mouthon, O Sitbon, G Simonneau, ... La Presse Médicale 40 (1), e87-e100, 2011 | 47 | 2011 |
| Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre D Montani, DS O'Callaghan, X Jais, L Savale, D Natali, A Redzepi, ... European Respiratory Review 18 (114), 272-290, 2009 | 41 | 2009 |
| Current management approaches to portopulmonary hypertension L Savale, DS O’Callaghan, R Magnier, J Le Pavec, P Hervé, X Jaïs, ... International Journal of Clinical Practice 65, 11-18, 2011 | 40 | 2011 |
| Portopulmonary hypertension L Savale, J Watherald, O Sitbon Seminars in Respiratory and Critical Care Medicine 38 (05), 651-661, 2017 | 38 | 2017 |
